Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 101940
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.101940
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.101940
Table 2 Median overall survival and recurrence-free survival according to cellular prion protein expression
| Characteristics | Low PrPC (n = 38) | High PrPC (n = 38) | P value |
| Median OS (95%CI), months | 137.9 (72.8-147.1) | 40.4 (11.2-59.1) | 0.041 |
| 3-year survival rate (%) | 28 (73.7) | 27 (71.1) | - |
| 5-year survival rate (%) | 27 (71.1) | 21 (55.3) | - |
| Median RFS (95%CI), months | 23.8 (15.6-133.6) | 13.3 (7.3-31.6) | 0.026 |
| 3-year recurrence-free rate (%) | 20 (52.6) | 18 (47.4) | - |
| 5-year recurrence-free rate (%) | 19 (50.0) | 16 (42.1) | - |
- Citation: Shin DW, Cho YA, Moon SH, Kim TH, Park JW, Lee JW, Choe JY, Kim MJ, Kim SE. High cellular prion protein expression in cholangiocarcinoma: A marker for early postoperative recurrence and unfavorable prognosis. World J Gastrointest Surg 2025; 17(3): 101940
- URL: https://www.wjgnet.com/1948-9366/full/v17/i3/101940.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i3.101940